The J. Craig Venter Institute Incorporates High-Performance Computing Solution from CLC bio
News Jul 15, 2009
The J. Craig Venter Institute (JCVI) in Rockville, Massachusetts, has recently incorporated CLC bio’s accelerated versions of the algorithms Hmmpfam and Hmmsearch into their bioinformatics pipeline for functional annotation of proteins identified in metagenomics data.
The algorithms originate from Dr. Sean Eddy's HMMER package but their core parts have been accelerated by CLC bio using SIMD technology.
Director of Bioinformatics Software at JCVI, Dr. Saul Kravitz, states “Given the ongoing acceleration in DNA sequencing capacity it is imperative for us to ensure that the bioinformatics pipelines we use to analyze sequencing data do not become bottlenecks to our researchers. The SIMD accelerated tools from CLC bio have given us a significant increase in analysis capacity that we could easily implement and take advantage of in our annotation pipeline without any further hardware investments.”
CEO of CLC bio USA, Jan Lomholdt, continues “We have worked closely with the scientists at JCVI and have used their input to expand the functionality of our algorithms to make them better suited for metagenomics analysis. Furthermore, it is a great confirmation of the level of our technology, to see our command-line tools incorporated in a professional high-throughput analysis pipeline at a leading research institution such as JCVI.”
CLC bio's command-line tool, CLC Bioinformatics Cell, uses the Single Instruction, Multiple Data (SIMD) technology to parallelize and thereby accelerate bioinformatics algorithms - like Hmmpfam, Hmmsearch, ClustalW, and Smith-Waterman - on Intel and AMD computer processors.
Watch: Could Digital Microfluidics Revolutionise Experimentation?News
Technology using 'programmable droplets' could enable automated research on a grand scale.READ MORE
New Research Could Significantly Accelerate Drug DiscoveryNews
Scientists have developed a suite of computer programs that cull through data on structure and genomic sequencing to identify the features that distinguish one enzyme from similar enzymes. This research has the potential to significantly accelerate drug discovery, allowing scientists to develop more effective drugs, more quickly.READ MORE
All in a Droplet: Atomic Resolution of ALS Protein ResolvedNews
Researchers have described atom-by-atom changes in a family of proteins linked to amyotrophic lateral sclerosis (ALS), a group of brain disorders known as frontotemporal dementia and degenerative diseases of muscle and bone.READ MORE